Qualcomm Is Worth More Than the Market Thinks
Apple will keep paying royalties even as it builds its own modems. That distinction, combined with a new Snapdragon platform, is not yet priced in.
Two Data Releases This Morning Could Decide Stocks’ Open
Durable goods at 8:30, final Michigan sentiment at 10:00: what it means for XLY, XLP, and SPY with markets pricing a 65% October hike chance.
Brent at $106.60 Cuts Both Ways. Here Is How to Stay Long Energy Without Getting Caught Offside.
The Hormuz deal headline that pared crude’s $108 spike also revealed exactly which energy names survive a reopening and which do not.
BlackRock Owns the Plumbing of Tokenized Finance Now
With $15.3 trillion in AUM and a $400 billion private markets target, BLK is not just riding the tokenization wave — it is building the pipes everyone else must use.
The $349 Ray-Ban Is Now Meta’s Real Bet
Meta’s audio-only Ray-Bans ship Oct. 13. They matter more to Reality Labs today than the $1,300 VR glasses due in spring 2027.
Royal Caribbean Is Paying $3 Billion for Half of Sandals. Investors Have Questions.
The market’s immediate verdict is a rebuke of CEO Jason Liberty’s capital allocation at the worst possible moment.
Shopify’s 7% Rally Reveals the Real Battle: Who Owns the Agentic Checkout?
Amazon is building a wall around its customers. Shopify is renting its rails to everyone. One of these strategies compounds for a decade.
AMD, Arm, and Intel Reset the AI Trade
When server processors surge past Nvidia in one session, investors have to ask whether GPUs are still the scarce asset.
The Rare Earth Sticking Point That Could Sink Thursday’s Summit
Markets are priced for a deal. Beijing’s Japan curbs suggest the terms are nowhere near settled.
Big Pharma’s Pipeline Is Now Made in China. Does Wall Street Know?
Treasury’s drug-licensing carve-out doesn’t just protect trade. It reveals how dependent major drugmakers already are on China to manage their patent cliffs.